Blueprint Medicines Corporation (BPMC) Covered Calls

Blueprint Medicines Corpis a biopharmaceutical company. It is focused on improving the lives of patients with genomically defined diseases driven by abnormal kinase activation.

You can sell covered calls on Blueprint Medicines Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for BPMC (prices last updated Fri 4:16 PM ET):

Blueprint Medicines Corporation (BPMC) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
94.15	-2.47	89.63	97.00	651K	-	6.1

Covered Calls For Blueprint Medicines Corporation (BPMC)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
Dec 20	95	2.00	95.00	0.0%	0.0%
Jan 17	95	4.40	92.60	2.6%	16.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Extended Business Description

Blueprint Medicines Corp. is a biopharmaceutical company, which engages in developing of kinase inhibitors for genomically defined subsets of cancer patients. It has developed a platform that combines genomics with a novel library of kinase inhibitors, enabling the development of potent highly selective compounds against clear genomic driver targets. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy in October 2008 and is headquartered in Cambridge, MA.

Top 10 Open Interest For Dec 20 Expiration				Top 5 High Yield
1.	NVDA covered calls	6.	QQQ covered calls	1.	SAVA covered calls
2.	SPY covered calls	7.	XLF covered calls	2.	CRVS covered calls
3.	EEM covered calls	8.	TLT covered calls	3.	APLT covered calls
4.	FXI covered calls	9.	KWEB covered calls	4.	ANAB covered calls
5.	IWM covered calls	10.	AAPL covered calls	5.	IREN covered calls

Want more examples? BP Covered Calls | BPOP Covered Calls